DOCSLIB.ORG

HEALTH CARE MANAGEMENT CLASS of 2014 PERMANENT PLACEMENT LIST COMPANY TITLE GROUP Location FINANCIAL SERVICES/VENTURE CAPITAL/P.E

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
HEALTH CARE MANAGEMENT CLASS of 2014 PERMANENT PLACEMENT LIST COMPANY TITLE GROUP Location FINANCIAL SERVICES/VENTURE CAPITAL/P.E HEALTH CARE MANAGEMENT CLASS OF 2014 PERMANENT PLACEMENT LIST COMPANY TITLE GROUP Location FINANCIAL SERVICES/VENTURE CAPITAL/P.E. Saurabh Bhansali HLM Venture Partners Senior Associate VC in HIT, Services and Devices San Francisco, CA Steven D. Bressler Riverside Partners Vice President Healthcare Boston, MA Qian Cai, PhD Citigroup Associate Healthcare Investment Banking New York, NY Edward S. Chung The Beekman Group Senior Associate New York, NY Nikhil Devulapalli Wendel Group, North America Senior Associate New York, NY John A. Harroff H.I.G. Capital Vice President LBO Group Miami, FL S. Jawad Hasan Apax Partners LLP Senior Associate Healthcare Team New York, NY Vivek Jain H.I.G. Capital Vice President New York, NY Eric W. Klein Bridge Growth Partners Vice President New York, NY Brian A. Lewandowski Tamarack Capital Management Analyst Carlsbad, CA Amanda H. Li Bank of America Merrill Lynch Associate Healthcare Investment Banking New York, NY Andrew (Drew) Z. Olian The Carlyle Group Senior Associate U.S. Equity Opportunity Fund New York, NY Ross D. Stern Summit Partners Vice President Health Care Boston, MA Geoffrey E. Tresley Mount Kellett Capital Director Distressed Private Equity New York William (Billy) B. Young Associate Lincoln International Mergers and Acquisitions New York, NY HC INFORMATION TECHNOLOGY/HC ANALYTICS Ambika K. Aggarwal athenahealth Product Manager Epocrates San Francisco, CA Brett L. Chung athenahealth Product Innovation Manager Epocrates San Francisco, CA Corbin R. Director RxAnte Director, Market Strategy McLean, VA Jane L. Herzeca Dabo Health Strategic Operations San Francisco, CA Mamta S. Patel Flatiron Health Point of Care Team New York, NY John Edward Pettengill VAL Health Director, Product Management Stamford, CT HEALTH CARE MANAGEMENT CONSULTING Andrew Adams Bain & Company Associate Chicago, IL Anne DeCourcy Conlin McKinsey & Company Associate Summit, NJ Elissa H. Bergman Deloitte Consulting Senior Consultant New York, NY Alexander (Alex) D. Blair Deloitte Consulting Senior Consultant Strategy San Francisco, CA Pablo Cervera McKinsey & Company Associate Mexico City Manuel L. Donnay The Boston Consulting Group Consultant San Francisco, CA Andrew Franklin The Boston Consulting Group Consultant Boston, MA Daniel K. Harvey The Boston Consulting Group Consultant New York, NY Breanna (Bre) Hockenbury McKinsey & Company Associate Business Technology Washington, DC Qiu Hen (Bob) Huang, MD Bain & Company Consultant Boston, MA J. Yang Lin Bain & Company Consultant New York, NY Grant W. Mitchell, MD McKinsey & Company Associate Sillcon Valley Office Palo Alto, CA Matthew Mouradian McKinsey & Company Associate Philadelphia, PA Ashwin R. Murthy Bain & Company Consultant Los Angeles, CA Gopal P. Pai, MD Bain & Company Consultant Health Care San Francisco, CA Diana F. Peng Bain & Company Consultant San Francisco, CA Andrew R. Ramish McKinsey & Company Associate Washington, DC Alcira Rodriguez Anton Deloitte Consulting Senior Consultant Human Capital New York, NY Andrew F. Shelton McKinsey & Company Associate New York, NY Jiarui (Carrie) Shi L.E.K. Consulting Consultant Shanghai, China Robert (Rob) P. Varady Deloitte Consulting Senior Consultant Strategy & Operations New York, NY Kevin Wu Deloitte Consulting Senior Consultant Washington, DC HEALTH CARE MANAGEMENT CLASS OF 2014 PERMANENT PLACEMENT LIST COMPANY TITLE GROUP Location HOSPITALS/PHYSICIAN GROUP PRACTICE Elena C. Castañeda ChenMed Clinical Efficiency Strategy Manager PMR Miami, FL Ryan S. Vass, MD The Children's Hospital of Philadelphia Project Manager Global Rare Diseases Registry Program Philadelphia, PA MANAGED CARE/INSURANCE Marisa Bass Emblem Health Product Development Lead Special Populations New York, NY Andrew (Andy) A. Glowalla Kaiser Permanente Senior Consultant Business Consulting & Implementation Los Angeles, CA Niti S. Kadakia Kaiser Permanente Manager Business Development & Innovation Oakland, CA MEDICAL RESIDENCY John S. Barbieri, MD Hospital of the University of Pennsylvania Resident Physician Dermatology Philadelphia, PA Frank Brodie, MD UCLA-Harbor Medical Center Resident Physician Los Angeles, CA Alexander (Alex) L. Chin, MD Stanford University Resident Physician Radiation Oncology Palo Alto, CA Penny Fang, MD MD Anderson Cancer Center Resident Physician Radiation Oncology Houston, TX Taylor Sewell, MD Children's Hospital of Philadelphia Resident Physician Pediatrics Philadelphia, PA PHARMACEUTICAL/BIOTECHNOLOGY/MED DEVICES Yuming A. Chiu Johnson & Johnson Associate Brand Manager McNeil Consumer Healthcare Fort Washington, PA Jennifer (Jenn) Anne D'Ascoli Genentech Market Planning Manager Patient Insights South San Francisco, CA Alan J. Han Genentech Manager San Francisco, CA Srinath (Sri) M. Kotte Natera Market Access & Product Sam Carlos, CA Nanxi Ling CVS Caremark Senior Manager Enterprise Innovation Woonsocket, RI Lauren A. Matise, PhD GlaxoSmithKline Esprit Associate (Rotational Program) Philadelphia, PA Yelena Ofengeym Orthotic Holdings Inc. Director, Financial Planning and Analysis Ronkonkoma, NY Stephen (Steve) D. Sweeny Medtronic Senior Associate, Corporate Development Minneapolis, MN Elizabeth (Liz) F. Weiss Purdue Pharma Manager Finance & Business Development Stamford, CT START-UP Robert (Rob) B. Bressler Teladoc Greenwich, CT Divya Dhar, MD Seratis Cofounder Startup Philadelphia, PA Masha Nikolski CoFounder & CEO PhaseOptics Los Angeles, CA Jaime Oriol LentesCol Co-founder Bogotá, Colombia Lauren E. Post Keas Director of Business Development San Francisco, CA Jennifer F. Rizk Picwell Vice President Product Development Philadelphia,PA OTHER Hee-Won Kang Unilever Associate Brand Manager Marketing Rotational Program Englewood Cliffs, NJ.
Load more

Recommended publications
  • Venture Capital & Private Equity Canadian Market Overview
    VC & PE CANADIAN MARKET OVERVIEW // 2017 CONTENTS PARTICIPATING DATA CONTRIBUTORS ............................................................................... 3 PRIVATE EQUITY CANADIAN MARKET OVERVIEW ...................................................... 17 PRIVATE EQUITY HIGHLIGHTS .................................................................................................................................... 18 FOREWORD ......................................................................................................................................4 PRIVATE EQUITY HEAT MAP // BUYOUT & ADD-ON DEALS ONLY ............................................... 19 VENTURE CAPITAL CANADIAN MARKET OVERVIEW .................................................... 5 PRIVATE EQUITY HEAT MAP // ALL PE DEALS ............................................................................................. 20 VENTURE CAPITAL HIGHLIGHTS ................................................................................................................................ 6 QUARTER-OVER-QUARTER PE INVESTMENT ACTIVITY ....................................................................... 21 VENTURE CAPITAL HEAT MAP ..................................................................................................................................... 7 TOP DISCLOSED CANADIAN PE DEALS OVER $500M ............................................................................ 22 QUARTER-OVER-QUARTER VC INVESTMENT ACTIVITY ........................................................................
    [Show full text]
  • Stepstone Atlantic Fund, L.P
    StepStone Atlantic Fund, L.P. Private Equity and Infrastructure Quarterly Monitoring Report For the period ending December 31, 2020 Report Prepared For: Important Information This document is meant only to provide a broad overview for discussion purposes. All information provided here is subject to change. This document is for informational purposes only and does not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, or as an offer to provide advisory or other services by StepStone Group LP, StepStone Group Real Assets LP, StepStone Group Real Estate LP, StepStone Conversus LLC, Swiss Capital Alternative Investments AG and StepStone Group Europe Alternative Investments Limited or their subsidiaries or affiliates (collectively, “StepStone”) in any jurisdiction in which such offer, solicitation, purchase or sale would be unlawful under the securities laws of such jurisdiction. The information contained in this document should not be construed as financial or investment advice on any subject matter. StepStone expressly disclaims all liability in respect to actions taken based on any or all of the information in this document. This document is confidential and solely for the use of StepStone and the existing and potential clients of StepStone to whom it has been delivered, where permitted. By accepting delivery of this presentation, each recipient undertakes not to reproduce or distribute this presentation in whole or in part, nor to disclose any of its contents (except to its professional advisors), without the prior written consent of StepStone. While some information used in the presentation has been obtained from various published and unpublished sources considered to be reliable, StepStone does not guarantee its accuracy or completeness and accepts no liability for any direct or consequential losses arising from its use.
    [Show full text]
  • NB Private Equity Partners: Overview Presentation
    NB Private Equity Partners: Overview Presentation Financial Information as of 30 September 2019, Unless Otherwise Noted November 2019 Why Invest in NBPE? Key Investment Merits Access to a portfolio of direct private equity investments, sourced from over 55 distinct private equity firms; diversified private company exposure without single GP risk Sourcing and execution through Neuberger Berman’s ~$80 billion private equity business Strong Historic Performance Capital appreciation from equity investments and income through dividend No second layer of management fees or carried interest on vast majority of direct investments, offering significant fee efficiency vs listed fund of funds vehicles1 1. Approximately 98% of the direct investment portfolio (measured on 30 September 2019 fair value) is on a no management fee, no carry basis to underlying third-party GPs. Key Information Document is available on NBPE’s website. NB PRIVATE EQUITY PARTNERS INVESTOR UPDATE 2 NBPE Position in the Listed Private Equity Landscape NBPE is focused on direct investments, invested alongside over 55 private equity sponsors Hyper Diversified Fund of Funds • Primary & Secondary, some co-investment NB Private Equity Partners exposure • Dual fee layer • Multi-Sponsor Exposure • Need to over-commit or • Single layer of fees on majority of 1 suffer cash drag direct investments Direct Focus, Single GP • Single GP Concentration Concentrated • Single fee layer at vehicle level, carry typically higher than NBPE Lower Higher Fee Efficiency Note: as of 30 September 2019. The above graphic is intended to be a representation of the funds’ investment strategy of direct vs fund investments and investments into third-party or funds managed by an affiliated investment manager of the listed company.
    [Show full text]
  • Overview Presentation Financial Information As of 31 August 2019, Unless Otherwise Noted October 2019 Why Invest in NBPE? Key Investment Merits
    NB Private Equity Partners: Overview Presentation Financial Information as of 31 August 2019, Unless Otherwise Noted October 2019 Why Invest in NBPE? Key Investment Merits Access to a portfolio of direct private equity investments, sourced from over 55 distinct private equity firms; diversified private company exposure without single GP risk Sourcing and execution through Neuberger Berman’s $74 billion private equity business Strong Historic Performance: 13.0% YTD IRR on direct equity investments; total portfolio 11.5% YTD IRR. Three year direct equity investments gross IRR of 18.6%; three year total portfolio gross IRR of 15.1% Capital appreciation from equity investments and income through dividend No second layer of management fees or carried interest on vast majority of direct investments, offering significant fee efficiency vs listed fund of funds vehicles1 1. Approximately 98% of the direct investment portfolio (measured on 31 August 2019 fair value) is on a no management fee, no carry basis to underlying third-party GPs. Key Information Document is available on NBPE’s website. NB PRIVATE EQUITY PARTNERS INVESTOR UPDATE 2 NBPE Position in the Listed Private Equity Landscape NBPE is focused on direct investments, invested alongside over 55 private equity sponsors Hyper Diversified Fund of Funds • Primary & Secondary, some co-investment NB Private Equity Partners exposure • Dual fee layer • Multi-Sponsor Exposure • Need to over-commit or • Single layer of fees on majority of 1 suffer cash drag direct investments Direct Focus, Single GP • Single GP Concentration Concentrated • Single fee layer at vehicle level, carry typically higher than NBPE Lower Higher Fee Efficiency Note: as of 31 August 2019.
    [Show full text]
  • NB Private Equity Partners Investor Presentation November 2020 THIS PRESENTATION CONTAINS FORWARD LOOKING STATEMENTS
    NB Private Equity Partners Investor Presentation November 2020 THIS PRESENTATION CONTAINS FORWARD LOOKING STATEMENTS THIS PRESENTATION HAS BEEN CREATED WITH THE BEST AVAILABLE INFORMATION AT THIS TIME. INFORMATION FLOW IN THE PRIVATE EQUITY ASSET CLASS OFTEN LAGS FOR SEVERAL MONTHS. THE PRESENTATION CONTAINS A LARGE AMOUNT OF FORWARD LOOKING STATEMENTS, PROJECTIONS AND PRO FORMA INFORMATION BASED UPON THAT AVAILABLE INFORMATION. THERE CAN BE NO ASSURANCE THAT THOSE STATEMENTS, PROJECTIONS AND PRO FORMA NUMBERS WILL BE CORRECT; ALL OF THEM ARE SUBJECT TO CHANGE AS THE UNDERLYING INFORMATION DEVELOPS. THE INFORMATION IN THIS PRESENTATION IS PRIMARILY BASED ON THE 31 AUGUST 2020 MONTHLY ESTIMATE IN WHICH 86% OF THE PRIVATE EQUITY FAIR VALUE IS BASED ON 30 JUNE 2020 PRIVATE VALUATION INFORMATION, AND 14% IS BASED ON 31 AUGUST 2020 VALUATION INFORMATION (6% IN PUBLIC SECURITIES AND 8% IN ROLLED FORWARD DEBT POSITIONS). THE 30 SEPTEMBER 2020 NBPE ESTIMATED MONTHLY NAV UPDATE WHICH WAS PUBLISHED ON 15 OCTOBER 2020 CONTAINED ONLY 14% OF VALUATION INFORMATION AS OF Q3 2020. AS A RESULT THE SEPTEMBER MONTHLY NAV UPDATE IS NOT DIRECTLY COMPARABLE TO PRIOR YEAR FIGURES WHICH HAVE BEEN UPDATED WITH FULL QUARTERLY INFORMATION. THE MAJORITY OF THIS PRESENTATION REMAINS BASED ON 31 AUGUST 2020 VALUATIONS. 2 NB Private Markets Overview An Industry Leader With An Attractive Track Record • 30+ years as a private market investor Co-investments $19 bn(1) Primaries $26 bn(1) • Committed ~$10 billion annually to private markets over the past 3 years Over $90 Secondaries • Unique position in the private market (1) Billion $12 bn ecosystem • A recognized private equity manager within Direct Private Credit the industry $6 bn Direct Specialty Strategies $7 bn GP Manager Stakes $22 bn _______________________ Note: As of June 30, 2020.
    [Show full text]
  • Nb Private Equity Partners: Investor Update April 2018 Financial Information As of 28 February 2018 Unless Otherwise Noted Nb Private Equity Partners Investor Update
    NB PRIVATE EQUITY PARTNERS: INVESTOR UPDATE APRIL 2018 FINANCIAL INFORMATION AS OF 28 FEBRUARY 2018 UNLESS OTHERWISE NOTED NB PRIVATE EQUITY PARTNERS INVESTOR UPDATE NB PRIVATE EQUITY PARTNERS (“NBPE”) To provide investors the opportunity for capital appreciation (through share price growth) and current income OBJECTIVE (through a regular dividend)… …by investing directly into private-equity backed companies, across the capital structure in the best relative value STRATEGY opportunities… MANAGER …using the sourcing and due diligence capabilities of Neuberger Berman’s $55 billion1 private equity platform… EFFICIENCY …with lower all-in costs to investors than other listed PE vehicles 1. Since inception through March 2018. Includes commitments still in the process of documentation. 2 NB PRIVATE EQUITY PARTNERS INVESTOR UPDATE NBPE’S MANAGER: NEUBERGER BERMAN Neuberger Berman manages over $55 billion in Private Equity DIRECT CREDIT $4BN1 KEY HIGHLIGHTS DIRECT SPECIALTY DIRECT EQUITY Industry Leadership: 30 years as a private equity investor; committed STRATEGIES $22BN1 approximately $7 billion annually(2) to private equity over the past three years $4BN1 Active Fund Relationships: LP in over 450 active private equity funds Experienced Investors: Expertise across fund investments, direct investments and income investments Deep Team: Over 140 dedicated private equity investment professionals with extensive networks Global Presence: Investment offices in New York, Dallas, Boston, London, Milan, Hong Kong and Bogota FUNDS $26BN1 LEADING, GLOBAL PRIVATE EQUITY PLATFORM Note: Represents aggregate committed capital since inception as of March 2018, including commitments in the process of documentation. 1. Committed capital from inception through March 2018, including dry powder. 2. Average over the past three years (2015 – 2017).
    [Show full text]
  • BGP FS Parent, Inc. Form D/A Filed 2017-03-01
    SECURITIES AND EXCHANGE COMMISSION FORM D/A Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(6) under the Act. [amend] Filing Date: 2017-03-01 SEC Accession No. 0001682591-17-000001 (HTML Version on secdatabase.com) FILER BGP FS Parent, Inc. Mailing Address Business Address C/O BRIDGE GROWTH C/O BRIDGE GROWTH CIK:1682591| IRS No.: 813367778 | State of Incorp.:DE PARTNERS, LLC, 510 MAD PARTNERS, LLC, 510 MAD Type: D/A | Act: 33 | File No.: 021-270270 | Film No.: 17654848 NEW YORK NY 10022 NEW YORK NY 10022 (212) 560-1170 Copyright © 2017 www.secdatabase.com. All Rights Reserved. Please Consider the Environment Before Printing This Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION OMB APPROVAL OMB Number: 3235-0076 Washington, D.C. 20549 June 30, Expires: FORM D 2012 Estimated average burden hours per 4.00 Notice of Exempt Offering of Securities response: 1. Issuer's Identity CIK (Filer ID Number) Previous Name(s) ☒ None Entity Type 0001682591 ☒Corporation Name of Issuer ☐ Limited Partnership BGP FS Parent, Inc. ☐ Limited Liability Company Jurisdiction of Incorporation/ Organization ☐ General Partnership DELAWARE ☐ Business Trust Year of Incorporation/Organization ☐Other ☐ Over Five Years Ago ☒ Within Last Five Years (Specify Year) 2016 ☐ Yet to Be Formed 2. Principal Place of Business and Contact Information Name of Issuer BGP FS Parent, Inc. Street Address 1 Street Address 2 C/O BRIDGE GROWTH PARTNERS, LLC, 510 MAD City State/Province/Country ZIP/Postal Code Phone No.
    [Show full text]
  • NB Private Equity Partners Investor Presentation January 2021 THIS PRESENTATION MAY CONTAIN FORWARD LOOKING STATEMENTS
    NB Private Equity Partners Investor Presentation January 2021 THIS PRESENTATION MAY CONTAIN FORWARD LOOKING STATEMENTS THIS PRESENTATION HAS BEEN CREATED WITH THE BEST AVAILABLE INFORMATION AT THIS TIME. INFORMATION FLOW IN THE PRIVATE EQUITY ASSET CLASS OFTEN LAGS FOR SEVERAL MONTHS. THE PRESENTATION MAY CONTAIN FORWARD LOOKING STATEMENTS, PROJECTIONS AND PRO FORMA INFORMATION BASED UPON THAT AVAILABLE INFORMATION. THERE CAN BE NO ASSURANCE THAT THOSE STATEMENTS, PROJECTIONS AND PRO FORMA NUMBERS WILL BE CORRECT; ALL OF THEM ARE SUBJECT TO CHANGE AS THE UNDERLYING INFORMATION DEVELOPS. THE INFORMATION IN THIS PRESENTATION IS BASED ON THE 31 DECEMBER 2020 MONTHLY ESTIMATE. 82% OF THE PRIVATE EQUITY FAIR VALUE IS BASED ON 30 SEPTEMBER 2020 PRIVATE VALUATION INFORMATION, AND 18% IS BASED ON 31 DECEMBER 2020 (12% IN PUBLIC SECURITIES AND 6% IN ROLLED FORWARD DEBT POSITIONS). FINAL Q4 VALUATION INFORMATION WILL BE INCORPORATED INTO THE ANNUAL REPORTED WHICH IS EXPECTED TO BE ISSUED IN APRIL 2021. 2 NBPE Overview NBPE invests directly in private equity backed companies and is listed on the LSE Key Highlights Value Proposition Listing Date: 2007 Direct private equity portfolio constructed primarily through equity co-investments Market Capitalisation (21/1/21): £568.1m Net Asset Value (NAV): $960.3m Investments sourced through Neuberger Berman’s ~$90 billion private equity business alongside over 50 high NAV per Share: $20.53 (£15.02) quality private equity firms NAV Total Return USD / GBP 1 year: 10.8% / 7.5% Goal of capital appreciation from equity investments and 3 year: 29.0% / 27.7% income through bi-annual dividend Share Price Total Return USD / GBP 1 year: 3.7% / 0.5% Fee efficient strategy: no second layer of management fees or carried interest on vast majority of direct 3 year: 26.9% / 25.6% investments1 2020 Avg.
    [Show full text]
  • DEAL DRIVERS AMERICAS the Comprehensive Review of Mergers and Acquisitions Throughout the Americas
    DEAL DRIVERS AMERICAS The comprehensive review of mergers and acquisitions throughout the Americas. 2014 FULL-YEAR EDITION Published by: In association with: Merrill DataSite® The Premier Global Due Diligence Platform The Premier Due Diligence Platform for M&A Transactions Merrill DataSite® is the premier global due diligence platform, offering superior virtual data room and document management services for M&A and other financial transactions. We provide first class security on a fully searchable and indexed workspace that enables users to access information around the clock for fast, efficient project close. Our dedicated team of multi-lingual project managers can open your VDR from anywhere in the world in a matter of hours and have it loaded with thousands of pages of data for review. Our global platform, first class security and premier service will help you expertly close your M&A transaction. [email protected] Deal Drivers (US Letter).indd 1 21/01/2015 17:04 03 Merrill DataSite® CONTENTS The Premier Global Foreword 04 Technology, Media & Telecom 30 New England 58 Due Diligence Platform Americas Heat Chart 05 Life Sciences & Healthcare 34 Latin America 62 All Sectors 06 Canada 38 About Merrill Corporation 66 and Merrill Datasite® Financial Services 14 West 42 Industrials, Manufacturing & Engineering 18 Midwest 46 Merrill Corporation Contacts 68 Energy, Mining, Oil & Gas 22 South 50 Notes 70 Consumer 26 Mid-Atlantic 54 ABOUT MERGERMARKET Mergermarket is an independent Mergers and Acquisitions (M&A) intelligence service with an unrivalled network of dedicated M&A journalists based in 62 locations across the Americas, Europe, The Premier Due Diligence Platform for M&A Transactions Asia-Pacific, the Middle-East and Africa.
    [Show full text]
  • Investor Update September 2017 Financial Information As of 31 July 2017 Unless Otherwise Noted Nb Private Equity Partners Investor Update
    NB PRIVATE EQUITY PARTNERS: INVESTOR UPDATE SEPTEMBER 2017 FINANCIAL INFORMATION AS OF 31 JULY 2017 UNLESS OTHERWISE NOTED NB PRIVATE EQUITY PARTNERS INVESTOR UPDATE NBPE OVERVIEW NBPE invests in private equity backed companies KEY HIGHLIGHTS INVESTMENT TYPE BY FAIR VALUE Listing Date: 2007 DIRECT EQUITY Market Capitalisation (31/7/17): £500.6m INVESTMENTS 68% Net Asset Value (NAV): $792.4m (£599.8m) NAV per Share: $16.24 (£12.29) NAV Total Return USD / GBP 1 year: 16.1% / 17.0% 3 year: 31.7% / 68.7% Share Price Total Return USD / GBP 1 year: 34.2% / 35.2% INCOME 3 year: 43.9% / 84.4% INVESTMENTS 16% 2017 Avg. Daily Trading Volume: ~100k shares per day FUND INVESTMENTS Current share price (7/9/17): £10.15 (~17% discount) 16% Dividend Yield (on Share Price): 3.7% Note: NBPE data as of 31 July 2017; GBP share price returns converted at daily GBP/USD close FX rates. Numbers may not sum due to rounding. All performance figures assume re-investment of dividends at NAV or closing share price on the ex- dividend date and reflect cumulative returns over the relevant time periods shown and are not annualised returns; share price return data based on the London Stock Exchange. Average trading volume represents daily average across London Stock Exchange, Euronext Amsterdam and over-the-counter trading platforms. 2 NB PRIVATE EQUITY PARTNERS INVESTOR UPDATE NBPE’S MANAGER: NEUBERGER BERMAN Neuberger Berman manages over $50 billion in Private Equity PRIVATE EQUITY PLATFORM Over $50 billion of commitments managed(1) FUND INVESTMENTS DIRECT INVESTMENTS
    [Show full text]
  • NB Private Equity Partners Investor Presentation 2021 Year to Date
    NB Private Equity Partners Investor Presentation 2021 Year to Date Update Investing in private companies to generate long-term growth 21 June 2021 THIS PRESENTATION MAY CONTAIN FORWARD LOOKING STATEMENTS THIS PRESENTATION HAS BEEN CREATED WITH THE BEST AVAILABLE INFORMATION AT THIS TIME. INFORMATION FLOW IN THE PRIVATE EQUITY ASSET CLASS OFTEN LAGS FOR SEVERAL MONTHS. THE PRESENTATION MAY CONTAIN FORWARD LOOKING STATEMENTS, PROJECTIONS AND PRO FORMA INFORMATION BASED UPON THAT AVAILABLE INFORMATION. THERE CAN BE NO ASSURANCE THAT THOSE STATEMENTS, PROJECTIONS AND PRO FORMA NUMBERS WILL BE CORRECT; ALL OF THEM ARE SUBJECT TO CHANGE AS THE UNDERLYING INFORMATION DEVELOPS. THE INFORMATION IN THIS PRESENTATION IS BASED ON THE 31 MAY 2021 MONTHLY NAV UPDATE, UNLESS OTHERWISE NOTED. 2 Neuberger Berman – A Leading Private Market Investor An industry leader with assets of over $70bn and a long track record of value creation A Global Private Markets Platform A Recognised Leader in ESG • 30+ years as a private market investor • A Leader in Responsible and Sustainable Investing • Over 150 investment personnel across 10 offices • NB Private Markets has been ESG-integrated in private equity investing since 2007 • Committed ~$13 billion annually on average to private markets over the past 3 years • Awarded an A+ Top Score in the most recent UN- supported Principles for Responsible Investment (PRI) • Unique position in the private market ecosystem assessment • A recognised private equity manager within the industry 3 NB Private Equity Overview Investing
    [Show full text]
  • Wharton Ebook 2018Pdf.Pdf
    Wharton MBA Program in Health Care Management 2018 RESUME BOOK Contents Program Description .......................4 Curriculum ...............................5 Graduates ............................6-30 Internship Sponsors.......................31 Health Care Program Mentors ...........32-36 Administration ..........................37 Faculty ..............................38-39 Thank you for your interest in the Wharton MBA Program in Health Care Management. For further information, resumes, and appointments, contact: June Kinney, Associate Director, MBA Program in Health Care Management The Wharton School University of Pennsylvania 3641 Locust Walk Philadelphia, PA 19104-6218 215.898.6861 | Fax 215.573.2157 email: [email protected] For information on the Wharton Health Care Management Alumni Association, visit www.whartonhealthcare.org For detailed information on the Health Care Management Department educational programs, visit http://mba.wharton.upenn.edu/healthcare/ 2018 Health Care Management M.B.A. Graduates The University of Pennsylvania was founded by Benjamin Franklin in 1740. Although the University carries the name of the Commonwealth, it is not a state university but an independent, private, nonsectarian institution. As one of the country’s earliest educational institutions, it has consistently initiated advances in teaching and research and has steadily generated specialized fields of higher education. Penn, as the University is commonly known, was the first American university to form departments of botany, hygiene and public health, surgical research, and research medicine. The University School of Medicine, formed in 1765, was the first in North America, as was the teaching hospital founded in 1874. The world’s first psychological clinic was opened at Penn in 1896. The Wharton School, in the same spirit of innovation and excellence, was the world’s first collegiate school of business and management.
    [Show full text]